Lisinopril vs amlodipine
Pro Research Analysisby 
Searched over 200M research papers
Blood Pressure Reduction: Lisinopril vs Amlodipine in Hypertension
Multiple studies have directly compared the effectiveness of lisinopril (an ACE inhibitor) and amlodipine (a calcium channel blocker) for lowering blood pressure in patients with hypertension. Research in Melanesian and Tanzanian populations found that both drugs significantly reduced systolic and diastolic blood pressure, with no significant difference in the degree of reduction between the two medications when used as monotherapy or in combination with a thiazide diuretic 14. This suggests that both lisinopril and amlodipine are similarly effective for initial blood pressure control in diverse patient groups.
Combination Therapy: Lisinopril and Amlodipine
Several studies highlight the benefits of using a fixed combination of lisinopril and amlodipine for hypertension management. This combination has been shown to provide strong antihypertensive effects, high safety, and good patient tolerance 2356+1 MORE. In large-scale and long-term studies, the fixed combination not only achieved target blood pressure in a significant proportion of patients but also demonstrated additional benefits such as improved organ protection (e.g., reduced proteinuria and prevention of heart remodeling) and metabolic neutrality 369. The combination is also effective in patients with comorbidities like arteriosclerosis obliterans and coronary heart disease 910.
Individual Response and Personalization
While both drugs are effective on average, there is notable individual variation in blood pressure response. Some patients may respond better to one drug over the other, suggesting that personalized treatment could further optimize blood pressure control . However, for most patients, either drug or their combination is likely to be effective.
Safety and Tolerability
Studies consistently report that both lisinopril and amlodipine, whether used alone or in combination, are well tolerated with few serious adverse events 2356. The combination therapy is also considered safe for long-term use and does not negatively impact metabolic parameters 36.
Special Populations and Additional Benefits
In patients with hypertension and additional cardiovascular risks or comorbidities, the combination of lisinopril and amlodipine has shown favorable outcomes, including better blood pressure control and improved prognostic endpoints compared to other combinations, such as amlodipine with valsartan . The combination also provides organ-protective effects, such as reducing proteinuria and improving vascular health 69.
Conclusion
Lisinopril and amlodipine are both effective options for lowering blood pressure, with no significant difference in efficacy when used alone. Their combination offers enhanced blood pressure control, safety, and organ protection, making it a strong choice for managing hypertension, especially in patients with high cardiovascular risk or comorbidities. Individual response may vary, so personalized treatment remains important for optimal outcomes.
Sources and full results
Most relevant research papers on this topic
PS 08-17 EFFECTIVENESS COMPARISON BETWEEN LISINOPRIL AND AMLODIPINE IN MELANESIAN PATIENTS WITH HYPERTENSION
Lisinopril and amlodipine both effectively reduce blood pressure in melanesian hypertensive patients, with no significant difference in effectiveness between the two drugs.
The optimal combination of Lysinopril and Amlodipine for the treatment of patients with hypertension
A fixed combination of lisinopril and amlodipine effectively and safely lowers blood pressure in patients with hypertension, preventing heart damage and improving metabolic health.
Amlodipine or Lisinopril in Combination with Bendroflumethiazide in Clinic Blood Pressure Control among Hypertensive Tanzanians with Moderate to Severe Hypertension: A Comparison Study
Both Amlodipine and Lisinopril in combination with Bendroflumethiazide effectively reduce blood pressure in native Tanzanian patients with stage 2 hypertension, with no significant difference between them.
DOI
Stability Indicating HPTLC Method for Simultaneous Determination of Amlodipine Besylate and Lisinopril in Combined Dose Tablet Formulation
The developed HPTLC method effectively separates Amlodipine besylate and Lisinopril in combined dose tablet formulation, offering a sensitive, rapid, and cost-effective method for simultaneous analysis.
Heterogeneity in Blood Pressure Response to 4 Antihypertensive Drugs: A Randomized Clinical Trial.
Personalized treatment targeting specific antihypertensive drugs can potentially provide an additional 4.4 mm Hg-lower systolic blood pressure for individuals with grade 1 hypertension.
Порівняльна ефективність і прогностичне значення фіксованої комбінації амлодипіну з інгібітором ангіотензинперетворювального ферменту або блокатором рецепторів ангіотензину 2 в пацієнтів з ішемічною хворобою серця, постінфарктним кардіосклерозом і гіпертонічною хворобою
Both lisinopril and amlodipine effectively control blood pressure in patients with coronary heart disease, post-infarction cardiosclerosis, and arterial hypertension, with no significant difference in BP indicators.
DOI